Outpatient hysteroscopic metroplasty with bipolar electrode is an effective treatment in patients with infertility related to septate uterus.
Outpatient hysteroscopic metroplasty with bipolar electrode is an effective treatment in patients with infertility related to septate uterus, according to observations from a clinical case series presented yesterday at the 42nd Global Congress on Minimally Invasive Gynecology, held just outside of Washington, DC, in National Harbor.
Angel G. Rincon, MD, from Maternidad Santa Maria, Merida, Venezuela, and Belkys I. Chacin, MD, of the Universidad de Los Andes, Merida, Venezuela, reported on the benefits of in-office hysteroscopic metroplasty using a 5F bipolar electrode, specifically with BipoTrode, for the treatment of septate uterus in 7 women with infertility. The mean age of the women who received the treatment was 27.4 years.
Septate uterus, the most common anomaly of the mllerian duct system, is associated with the poorest reproductive outcomes of all uterine malformations. Early presenting symptoms generally involve menstrual disorders. Late presentations of the condition are obstetric complications or infertility.
Rincon reported that of the 7 hysteroscopic metroplasties performed, paracervical analgesia was required by 4 patients (57%) because of discomfort during passage through the cervical canal. Saline solution was used as distention media in all 7 procedures, the average procedure time of each was 25.6 minutes.
There were no complications during the procedure or reported during an 8-month follow-up period. Also during the 8-month follow-up period, 4 patients (57%) became pregnant and no spontaneous abortions were reported.
“These results show that use of outpatient hysteroscopy with bipolar electrode is an effective way for the treatment of patients with septate uterus,” Rincon concluded.
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More
Study: Pelvic floor dilator reduces pelvic floor muscle injury during vaginal delivery
August 6th 2024A new pilot study published in the International Urogynecology Journal found that Materna Medical’s Prep Device, a pelvic floor dilator, reduced full levator ani muscle avulsion during vaginal delivery in first-time mothers.
Read More
Similar success rates for synthetic and nonsynthetic slings in SUI treatment
July 31st 2024A study found that both synthetic and nonsynthetic slings show similar success rates for treating stress urinary incontinence in women, with synthetic slings demonstrating improved operative outcomes and reduced complications.
Read More
First hysterectomy using miniaturized MIRA Surgical System performed
July 30th 2024Virtual Incision Corporation has announced the successful performance of the first benign hysterectomy using their miniaturized robotic-assisted surgery device, MIRA, in a clinical trial assessing its safety and efficacy.
Read More